Atlas Trials

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Clinical trial NCT04190823 · UNKNOWN

Trial details

NCT number
NCT04190823
Sponsor
RemeGen Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2020-03-15
Primary completion
2023-12-28
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.